Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic reviewRenal Replacement Therapy - Tập 5 Số 1 - 2019
Yukio Maruyama, Chieko Higuchi, Hiroaki Io, Keiichi Wakabayashi, Hiraku Tsujimoto, Yasushi Tsujimoto, Hidemichi Yuasa, Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto
AbstractBackgroundDiabetes has become the most common cause of end-stage renal
disease (ESRD) requiring renal replacement therapy (RRT) in most countries
around the world. Peritoneal dialysis (PD) is valuable for patients newly
requiring RRT because of the preservation of residual renal function (RRF),
higher quality of life, and hemodynamic stability in comparison with
hemodialysis (HD). A previo... hiện toàn bộ
Evaluation of factors related to depression in peritoneal dialysis patients: a multicenter cross-sectional studyRenal Replacement Therapy - Tập 9 - Trang 1-7 - 2023
Sepehr Bazazzadeh, Mohammad Reza Sharbafchi, Maryam Kazemi Naeini, Sayed Mohsen Hosseini, Abdolamir Atapour, Mojgan Mortazavi
End-stage renal disease (ESRD) is serious global public health challenge in many
developing countries. Treatment of ESRD is carried out through renal replacement
therapy like peritoneal dialysis (PD). Depression is the most common mood
disorder which has a strong impact on the quality of life in patients with ESRD.
Little is known about the prevalence and risk factors of depression in
peritoneal d... hiện toàn bộ
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19Renal Replacement Therapy - Tập 8 Số 1 - 2022
Masataro Toda, Ayumi Yoshifuji, Kentaro Fujii, Motoaki Komatsu, Atsushi Kato, Ikue Tamura, Wataru Sugi, Munekazu Ryuzaki
Abstract Background We experienced that some hemodialysis (HD) patients with
coronavirus disease 2019 (COVID-19) exacerbated hypoxemia during HD. Though
HD-induced hypoxemia has been reported, there have been no reports of HD-induced
hypoxemia in patients with COVID-19 and its effect on prognosis of COVID-19.
Methods Eleven HD patients admitted with COVID-19 from August 2020 to April 2021
were cla... hiện toàn bộ
Frailty and mortality among dialysis patientsRenal Replacement Therapy - Tập 3 - Trang 1-6 - 2017
Kosaku Nitta, Norio Hanafusa, Ken Tsuchiya
Frailty is a clinical state in which there is an increase in the individual’s
vulnerability to developing increased dependency and/or mortality when exposed
to a stressor. Since the mean age of dialysis patients is increasing worldwide,
frailty has recently come to be considered one of the risk factors for mortality
in the older dialysis population. The prevalence of frailty among dialysis
patient... hiện toàn bộ
A simple protein-energy wasting score for survival prediction of maintenance hemodialysis patientsRenal Replacement Therapy - Tập 1 - Trang 1-6 - 2015
Sonomi Kobayashi, Keiko Suzuki, Mio Ueda, Yoshiko Tanaka, Kosaku Nitta
The nutritional status of patients on maintenance hemodialysis (MHD) is a strong
predictor of their survival. We assessed the reliability of a protein-energy
wasting (PEW) score as a predictor of the survival of Japanese MHD patients. The
study subjects were 254 MHD patients. PEW score was from 0 (worst; group 1) to 4
(best; group 4) and was derived from four body nutrition compartments: serum
alb... hiện toàn bộ
Usefulness of the Japanese version of the 5-D itch scale for rating pruritus experienced by patients undergoing hemodialysisRenal Replacement Therapy - Tập 4 - Trang 1-10 - 2018
Naoko Takahashi, Taku Yoshizawa, Aiko Okubo, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi, Takao Masaki, Toshiya Ebata
Pruritus in patients undergoing hemodialysis reduces quality of life via
insomnia and depression, and negatively affects prognosis. For diagnosing
pruritus, selecting therapeutic strategies, and determining therapeutic
outcomes, methods are needed for objectively quantifying the degree of
itchiness. In 2015, the Japanese version of the 5-D itch scale (5D-J),
originally developed in the USA in 2010... hiện toàn bộ
Intermittent infusion hemodiafiltration is associated with improved survival compared to hemodialysisRenal Replacement Therapy - - 2024
Masanori Abe, Kan Kikuchi, Atsushi Wada, Shigeru Nakai, Norio Hanafusa
Approximately 16.4% of patients on hemodialysis (HD) in Japan are treated with
intermittent infusion hemodiafiltration (I-HDF). However, large-scale data on
clinical outcomes with this modality are lacking. This study aimed to compare
the outcomes of I-HDF with those of conventional HD. A cohort study was
conducted using the Japanese Society for Dialysis Therapy Renal Data Registry
database from D... hiện toàn bộ
Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilizationRenal Replacement Therapy - Tập 3 - Trang 1-7 - 2017
Tomoyuki Kawano, Tadashi Kuji, Tetsuya Fujikawa, Eiko Ueda, Midori Shino, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura, Nobuhito Hirawa, Yoshiyuki Toya
We recently demonstrated, using an index of recently synthesized hemoglobin,
reticulocyte hemoglobin (Ret-Hb), that iron administration remarkably improves
hemoglobin (Hb) synthesis during the period of high activation of erythropoiesis
induced by the administration of a continuous erythropoietin receptor activator
(CERA). We aimed to investigate whether repetition of iron dosing sustains
effectiv... hiện toàn bộ